close 74% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Home・Aandelen Lijst・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Gesloten

SectorGezondheidszorg

16.54 -0.42

Buy

Prijsupdate 15 aug 2025, 19:58 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.33

Max

16.77

Belangrijke statistieken

By Trading Economics

Inkomsten

-53M

-20M

EPS

-2.27

Werknemers

103

EBITDA

8.4M

-19M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-16.12% downside

Dividenden

By Dow Jones

Volgende Winsten

12 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.9M

127M

Vorige openingsprijs

16.96

Vorige sluitingsprijs

16.54

Nieuwssentiment

By Acuity

19%

81%

26 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

N/A / 9.31 Steun & Weerstand

Seres Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 aug 2025, 16:11 UTC

Belangrijke Marktbewegers

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

DJ

Lezen

15 aug 2025, 22:22 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

15 aug 2025, 22:22 UTC

Marktinformatie

Target Is Falling Behind Its Peers -- Market Talk

DJ

Lezen

15 aug 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

15 aug 2025, 20:33 UTC

Marktinformatie

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

DJ

Lezen

15 aug 2025, 20:25 UTC

Winsten
Acquisities, Fusies, Overnames

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

DJ

Lezen

15 aug 2025, 20:24 UTC

Winsten
Acquisities, Fusies, Overnames

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

DJ

Lezen

15 aug 2025, 20:18 UTC

Winsten

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

DJ

Lezen

15 aug 2025, 19:14 UTC

Marktinformatie

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

DJ

Lezen

15 aug 2025, 19:12 UTC

Marktinformatie

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

DJ

Lezen

15 aug 2025, 18:32 UTC

Marktinformatie

Coffee Futures Surge on New Brazilian Frost -- Market Talk

DJ

Lezen

15 aug 2025, 17:33 UTC

Marktinformatie

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

DJ

Lezen

15 aug 2025, 17:23 UTC

Marktinformatie
Winsten

Deere's Earnings Appear to Be Troughing -- Market Talk

DJ

Lezen

15 aug 2025, 16:27 UTC

Winsten

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

DJ

Lezen

15 aug 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

15 aug 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

15 aug 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

15 aug 2025, 16:05 UTC

Acquisities, Fusies, Overnames

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

DJ

Lezen

15 aug 2025, 15:52 UTC

Acquisities, Fusies, Overnames

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

DJ

Lezen

15 aug 2025, 15:36 UTC

Marktinformatie

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

DJ

Lezen

15 aug 2025, 15:29 UTC

Winsten

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

DJ

Lezen

15 aug 2025, 15:29 UTC

Acquisities, Fusies, Overnames

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

DJ

Lezen

15 aug 2025, 15:28 UTC

Winsten

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

DJ

Lezen

15 aug 2025, 15:24 UTC

Marktinformatie

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

DJ

Lezen

15 aug 2025, 15:08 UTC

Marktinformatie

Applied Materials Is Losing Share in Chips Business -- Market Talk

DJ

Lezen

15 aug 2025, 14:38 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

DJ

Lezen

15 aug 2025, 14:37 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

DJ

Lezen

15 aug 2025, 14:37 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

DJ

Lezen

15 aug 2025, 14:36 UTC

Acquisities, Fusies, Overnames

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

DJ

Lezen

15 aug 2025, 14:33 UTC

Acquisities, Fusies, Overnames

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Seres Therapeutics Inc Prognose

Koersdoel

By TipRanks

-16.12% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 14 USD  -16.12%

Hoogste 14 USD

Laagste 14 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Seres Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Seres Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 9.31Steun & Weerstand

Korte Termijn

Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

26 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

701.97

↑ +2.52%

JNJ

Johnson and Johnson

176.85

↑ +1.02%

ABBV

AbbVie Inc

206.8

↑ +1%

NVS

Novartis AG

123.84

↑ +1.28%

AZN

AstraZeneca PLC ADR

79.17

↑ +0.81%